Skip to main content

Home BP Monitoring Can Cut Burden of CVD, Health Care Costs

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

TUESDAY, July 18, 2023 -- Home blood pressure monitoring can reduce the burden of cardiovascular disease and reduce health care costs, according to a study recently published in the American Journal of Preventive Medicine.

Yan Li, Ph.D., from the School of Public Health at the Shanghai Jiao Tong University School of Medicine, and colleagues used a previously developed microsimulation model of cardiovascular disease to estimate the long-term impact of adopting home blood pressure monitoring versus usual care on myocardial infarction, stroke, and health care costs. Averted cases of myocardial infarction and stroke and health care cost savings were estimated in U.S. adults with hypertension and in subpopulations defined by sex, race, ethnicity, and rural/urban area.

The researchers found that adopting home blood pressure monitoring was estimated to reduce myocardial infarction and stroke cases by 4.9 and 3.8 percent, respectively, and to save an average of $7,794 in health care costs per person over 20 years. More averted cardiovascular events and greater cost savings related to adopting home blood pressure monitoring were seen for non-Hispanic Blacks, women, and rural residents compared with non-Hispanic Whites, men, and urban residents.

"Our study is among the first to assess the potential health and economic impact of adopting home blood pressure monitoring among American adults with hypertension," Li said in a statement. "We found that it facilitates early detection, timely intervention, and prevention of complications, leading to improved control and better health outcomes."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

HTN, Albuminuria Risks No Worse for Kidney Donors Versus Nondonors

THURSDAY, May 30, 2024 -- Living kidney donors and nondonors have similar risks for hypertension and albuminuria, according to a study published online May 23 in the Journal of...

DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD

WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...

Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease

TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.